BioCentury
ARTICLE | Company News

Arix, Fosun in China-focused deal

February 23, 2018 8:36 PM UTC

Life sciences investment firm Arix Bioscience plc (LSE:ARIX) partnered with Fosun International Ltd. (HKSE:656) to invest in and build newcos focused on the China market.

The deal will give Arix access to investment opportunities in China, while Fosun will have a "potential opportunity" to serve as an exclusive distribution partner in China for Arix's portfolio companies, the partners said...